利奈唑胺抗结核活性与毒性的药效动力学关联:小鼠模型研究
该研究在小鼠急性与慢性结核感染模型中建模利奈唑胺多剂量药代动力学,评估药效学参数与肺菌落形成单位及血常规的相关性。结果显示,高于最低抑菌浓度的时间(T>MIC)与菌落下降相关性最佳,但在细菌增殖受限时AUC/MIC预测力相当;红细胞计数与利奈唑胺最低浓度(Cmin)强相关。提示有效联合方案中减少给药频率可能保持疗效并降低Cmin依赖性毒性。
要点
- T>MIC是利奈唑胺疗效最一致的药效学关联指标。
- 宿主免疫或pretomanid限制细菌增殖时,AUC/MIC预测力与T>MIC相当。
- 红细胞计数与利奈唑胺Cmin强相关,提示Cmin依赖性毒性。
核心结论
- T>MIC是利奈唑胺疗效最一致的药效学关联指标,但在细菌增殖受限时AUC/MIC同样具有预测力。
- 红细胞计数与利奈唑胺最低浓度(Cmin)强相关,提示Cmin依赖性血液毒性。
- 在有效联合方案中,相同总剂量降低给药频率可能疗效相当且减少Cmin依赖性毒性。
研究设计与样本
- 小鼠多剂量药代动力学建模研究。
- 在急性(净细菌生长)和慢性(无净生长)感染模型中开展剂量分割研究。
- 急性模型中利奈唑胺单用或联用抑菌或杀菌剂量的pretomanid。
- 评估PK/PD参数与肺菌落形成单位(CFUs)及全血细胞计数的相关性。
主要发现
- 总体上,高于最低抑菌浓度的时间(T>MIC)与CFU下降相关性最佳。
- 在生长受限模型(慢性感染、联用pretomanid 50 mg/kg每日)中,AUC/MIC具有相似的解释力。
- 红细胞计数与利奈唑胺最低浓度(Cmin)强相关。
临床怎么用
- 在有效联合方案中,可考虑相同总剂量降低给药频率以保持疗效并减少Cmin依赖性毒性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Linezolid (LZD) is bactericidal against Mycobacterium tuberculosis, but it has treatment-limiting toxicities. A better understanding of exposure-response relationships governing LZD efficacy and toxicity will inform dosing strategies. Because in vitro monotherapy studies yielded conflicting results, we explored LZD pharmacokinetic/pharmacodynamic (PK/PD) relationships in vivo against actively and nonactively multiplying bacteria, including in combination with pretomanid. METHODS: Linezolid multidose pharmacokinetics were modeled in mice. Dose-fractionation studies were performed in acute (net bacterial growth) and chronic (no net growth) infection models. In acute models, LZD was administered alone or with bacteriostatic or bactericidal pretomanid doses. Correlations between PK/PD parameters and lung colony-forming units (CFUs) and complete blood counts were assessed. RESULTS: Overall, time above minimum inhibitory concentration (T>MIC) correlated best with CFU decline. However, in growth-constrained models (ie, chronic infection, coadministration with pretomanid 50 mg/kg per day), area under the concentration-time curve over MIC (AUC/MIC) had similar explanatory power. Red blood cell counts correlated strongly with LZD minimum concentration (Cmin). CONCLUSIONS: Although T>MIC was the most consistent correlate of efficacy, AUC/MIC was equally predictive when bacterial multiplication was constrained by host immunity or pretomanid. In effective combination regimens, administering the same total LZD dose less frequently may be equally effective and cause less Cmin-dependent toxicity.
引用
- Bigelow KM, Deitchman AN, Li SY, et al. Pharmacodynamic Correlates of Linezolid Activity and Toxicity in Murine Models of Tuberculosis. J Infect Dis. 2021. PMID: 31993638. doi:10.1093/infdis/jiaa016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。